International Journal of Education and Management Engineering (IJEME)
IJEME Vol. 12, No. 2, 8 Apr. 2022
Cover page and Table of Contents: PDF (size: 988KB)
Decision Support System for Drug-Drug Interaction Pertaining to COPD and its Comorbidities
Full Text (PDF, 988KB), PP.1-6
Views: 0 Downloads: 0
Author(s)
Sudhir Anakal
1,*
P Sandhya
2
Index Terms
Drug-Drug Interaction (DDI), Drug Decision Support System (DDSS), Chronic Obstructive Pulmonary Disease (COPD)
Abstract
A Drug-Drug Interaction is an alteration in the impact of a drug when consolidated with another drug or group of drugs. Drug interactions are common and have caused increased hospital admission rates, treatment failures, avoidable medical complications, and even deaths. Studies have found multiple drug usage, and age-related comorbidities to be the reasons for the interactions and this demands a general study. Here in this paper, we discuss the Drug-Drug Interactions between Chronic Obstructive Pulmonary Disease (COPD) and its associated comorbidity diseases. We have designed a Drug Decision Support System which helps the Physicians to check the Drug-Drug interaction between Chronic Obstructive Pulmonary Disease and its associated comorbidity diseases. COPD is a fourth decade disease means after age 40 it may be diagnosed and is currently fourth largest killing disease. Study says one of the major cause for COPD is smoking (active/passive). As there is no cure for COPD yet. The patient’s life can be improved by providing better treatment and management strategies. Once the patient is diagnosed with COPD the patient may also end up suffering with the comorbidity diseases associated with COPD like Asthma, Depression, Dementia, Diabetics, Heart Failure, Hypertension, Hypotension, Obesity, and Osteoporosis. The patient has no choice but taking the prescribed drugs for COPD and other comorbidity disease he is suffering from. Therefore the proposed work plays a vital role in avoiding the drug-drug interaction between COPD and its associated comorbidity diseases.
Cite This Paper
Sudhir Anakal, P Sandhya, "Decision Support System for Drug-Drug Interaction Pertaining to COPD and its Comorbidities", International Journal of Education and Management Engineering (IJEME), Vol.12, No.2, pp. 1-6, 2022. DOI: 10.5815/ijeme.2022.02.01
Reference
[1]Clinical Pharmacology, “Study Design, Data Analysis, Implications for Dosing, and Labeling Recommendations U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER)”, Drug Interaction Studies, February 2012.
[2]Angela D. M. Kashuba and Joseph S. Bertino, “Mechanisms of Drug Interactions”, Springer, 2005.
[3]Abha Moitra, Ravi Palla, andLuis Tari, “Semantic Inference for Pharmacokinetic Drug-Drug Interactions”, IEEE International Conference on Semantic Computing, June 2014.
[4]Mellar P. Davis and Declan Walsh, “Methadone for relief of cancer pain: a review of pharmacokinetics, pharmacodynamics, drug interactions and protocols of administration”, Springer, Verlag 2012.
[5]World Health Statistics, World Health Organization, 2009.
[6]National Health Statics Report – Number 97 - July 27 2016.
[7]Tatonetti NP, and Fernald GH, Altman RB “A novel signal detection algorithm for identifying hidden drug-drug interactions in adverse event reports”, Epub, June 14 2011.
[8]Isabel Segura-Bedmar, Paloma Mart´ınez, and Mar´ıa Herrero-Zazo, “Extraction of Drug-Drug Interactions from Biomedical Texts (DDIExtraction 2013)”, Atlanta, Georgia, June 2013.
[9]Sathien Hunta, Nattapol Aunsri, and Thongchai Yooyativong, “Drug-Drug Interactions Prediction from Enzyme Action Crossing through Machine Learning Approaches”, Electrical Engineering/Electronics, Computer, Telecommunications and Information Technology (ECTI-CON), 2015 12th International Conference, June 2015.
[10]Di Liu, Tao Gu, and J Iang-P Ing Xue, “Rule Engine Based On Improvement Rete Algorithm”, Apperceiving Computing and Intelligence Analysis (ICACIA), 2010.